Recombinant multi-species ACC1/ACACA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ACC1/ACACA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. There are two ACC forms, alpha and beta, encoded by two different genes. ACC-alpha is highly enriched in lipogenic tissues. The enzyme is under long term control at the transcriptional and translational levels and under short term regulation by the phosphorylation/dephosphorylation of targeted serine residues and by allosteric transformation by citrate or palmitoyl-CoA. Multiple alternatively spliced transcript variants divergent in the 5' sequence and encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: A530025K05Rik,ACAC,ACACA,ACACAD,ACACalpha,ACC,ACC1,ACCA,ACCalpha,Acac,Acac1,Acaca,Acc1,Acetyl-CoA carboxylase 1,Acetyl-Coenzyme A carboxylase alpha (ACC-alpha),Gm738,hACC1

Target products collectionGo to ACC1/ACACA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7940-Ag-1/ GM-Tg-hg-IP7940-Ag-2 Human ACC1/ACACA protein Human
GM-Tg-rg-IP7940-Ag-1/ GM-Tg-rg-IP7940-Ag-2 Rat ACC1/ACACA protein Rat
GM-Tg-mg-IP7940-Ag-1/ GM-Tg-mg-IP7940-Ag-2 Mouse ACC1/ACACA protein Mouse
GM-Tg-cynog-IP7940-Ag-1/ GM-Tg-cynog-IP7940-Ag-2 Cynomolgus/Rhesus macaque ACC1/ACACA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7940-Ag-1/ GM-Tg-felg-IP7940-Ag-2 Feline ACC1/ACACA protein Feline
GM-Tg-cang-IP7940-Ag-1/ GM-Tg-cang-IP7940-Ag-2 Canine ACC1/ACACA protein Canine
GM-Tg-bovg-IP7940-Ag-1/ GM-Tg-bovg-IP7940-Ag-2 Bovine ACC1/ACACA protein Bovine
GM-Tg-equg-IP7940-Ag-1/ GM-Tg-equg-IP7940-Ag-2 Equine ACC1/ACACA protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7940-Ag-1/ GM-Tg-hg-IP7940-Ag-2; GM-Tg-rg-IP7940-Ag-1/ GM-Tg-rg-IP7940-Ag-2;
GM-Tg-mg-IP7940-Ag-1/ GM-Tg-mg-IP7940-Ag-2; GM-Tg-cynog-IP7940-Ag-1/ GM-Tg-cynog-IP7940-Ag-2;
GM-Tg-felg-IP7940-Ag-1/ GM-Tg-felg-IP7940-Ag-2; GM-Tg-cang-IP7940-Ag-1/ GM-Tg-cang-IP7940-Ag-2;
GM-Tg-bovg-IP7940-Ag-1/ GM-Tg-bovg-IP7940-Ag-2; GM-Tg-equg-IP7940-Ag-1/ GM-Tg-equg-IP7940-Ag-2
Products Name ACC1/ACACA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ACC1/ACACA
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ACC1/ACACA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.